Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IMCR
#2045
Immunocore Holdings plc - American Depositary Shares
36.6
2
USD
0.00%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-0.35%
Monthly Change
+10.10%
6 month change
+14.69%
Year Change
+9.38%
Previous Close
36.7
5
Open
36.6
2
Low
36.6
2
High
36.6
2
Volume
38
Markets
US Stock Market
Healthcare
Biotechnology
IMCR
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
31.78 M
43.86 M
48.09 M
49.82 M
50.07 M
50.7 M
51.5 M
Valuation ratios
Enterprise value
—
1.5 B
2.67 B
3.17 B
1.41 B
1.69 B
1.83 B
Price to earnings ratio
—
—
—
-63.4
-28.92
-48.89
-98.39
Price to sales ratio
—
—
—
14.04
4.75
4.37
4.44
Price to cash flow ratio
—
—
—
1 191.29
56.59
-163.13
-54.6
Price to book ratio
—
—
—
9.5
4.09
4.59
1.2
Enterprise value to EBITDA ratio
—
—
—
-57.15
-21.31
-39.88
-96.71
Profitability ratios
Return on assets %
—
—
—
-0.09
-0.05
-0.03
-0
Return on equity %
—
—
—
-0.15
-0.14
-0.09
-0
Return on invested capital %
—
—
—
-126.09
-131.84
-126.65
-7.24
Gross margin %
—
—
—
99.58
99.12
98.73
99.06
Operating margin %
—
—
—
-23.91
-22.71
-11.34
-2.58
EBITDA margin %
—
—
—
-22.27
-21.36
-10.56
-1.7
Net margin %
—
—
—
-22.17
-16.47
-8.88
-0.7
Liquidity ratios
Quick ratio
—
—
—
3.77
4.36
4.01
4.44
Current ratio
—
—
—
3.8
4.38
4.04
4.47
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
—
0.42
0.39
0.37
0.11
Solvency ratios
Debt to assets ratio
—
—
—
0.08
0.39
0.37
0.35
Debt to equity ratio
—
—
—
0.13
1.08
1.03
0.94
Long term debt to total assets ratio
—
—
—
0.17
0.39
0.37
0.35
Long term debt to total equity ratio
—
—
—
0.27
1.08
1.03
0.94
Per share metrics
Operating cash flow per share
—
—
—
0.06
0.52
-0.21
-0.68
EBIT per share
—
—
—
-1.22
-1.41
-0.9
-0.45
EBITDA per share
—
—
—
-1.14
-1.33
-0.84
-0.38
Total debt per share
—
—
—
0.98
7.82
7.81
7.73
Cash per share
—
—
—
9.05
16.41
17.16
17.27
Net current asset value per share
—
—
—
10.82
18.6
19.8
20.62
Tangible book value per share
—
—
—
7.54
7.22
7.57
8.24
Working capital per share
—
—
—
7.97
14.36
14.9
16.01
Book value per share
—
—
—
7.54
7.22
7.57
8.24
News
Will Kimmtrak Continue to Aid IMCR's Growth Through the Rest of 2026?
Making Drugs With AI: Biopharma Giants Gear Up For New Arena
IMCR Jumps 21.2% in 3 Months as Kimmtrak Growth Fuels More Momentum
Is IMCR Worth Buying as Kimmtrak Growth Meets a Premium Valuation?
IMCR Q2 Revenues Climb 18.3% as Kimmtrak Demand Helps Offset EPS Miss
Immunocore's Q2 Earnings Miss Estimates, Kimmtrak Aids Y/Y Revenues
Wall Street Analysts See a 77.91% Upside in Immunocore (IMCR): Can the Stock Really Move This High?
Immunocore Holdings plc (IMCR) Q2 2026 Earnings Call Transcript
How Immunocore Is Expanding Beyond Its Rare-Cancer Drug Kimmtrak
Is Immunocore Stock Attractive After Kimmtrak's Strong Sales Growth?
Immunocore's Kimmtrak Growth Story and Major 2026 Catalysts Ahead
Gilead Leads The Battle Vs. HIV. But Rivals Are On The Move.